Diurnal en es it fr

Diurnal Brand names, Diurnal Analogs

Diurnal Brand Names Mixture

  • No information avaliable

Diurnal Chemical_Formula


Diurnal RX_link

No information avaliable

Diurnal fda sheet

Diurnal msds (material safety sheet)

Diurnal Synthesis Reference

No information avaliable

Diurnal Molecular Weight

309.469 g/mol

Diurnal Melting Point

< 25 oC

Diurnal H2O Solubility

Soluble as HCl salt

Diurnal State


Diurnal LogP


Diurnal Dosage Forms

Tablets (oral, 1 mg)

Diurnal Indication

Used for the symptomatic treatment of parkinsonism.

Diurnal Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Diurnal Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Diurnal side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Diurnal Patient Information

Diurnal Organisms Affected

Humans and other mammals